Steven Nissen takes developer’s side of cholesterol drug debate
Dr. Steven Nissen, the Cleveland Clinic’s high-profile cardiovascular medicine chair, is staking his reputation as a drug-safety advocate on a shortened regulatory pathway for a cholesterol-fighting drug made by a Swedish company, according to a report in the May 31 issue of Bloomberg Businessweek. Nissen is interested in eprotirome, developed by Karo Bio AB, because […]